Effect of permeation enhancers on the in vitro percutaneous absorption of pentazocine

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 7, 2007, Pages 1350-1353

  Furuishi, Takayuki ^a   Sachiko, Oda ^a   Saito, Hiroaki ^a   Fukami, Toshiro ^a   Suzuki, Toyofumi ^a   Tomono, Kazuo ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Glycerol ester; Hydrophilic lipophilic balance (HLB); Isopropyl myristate; Pentazocine; Permeation enhancer

Indexed keywords

1 METHYL 2 PYRROLIDINONE; ALCOHOL; CITRIC ACID; DIOCTANOIN; GLYCERYL CAPROATE; MONOACYLGLYCEROL; MYRISTIC ACID ISOPROPYL ESTER; OCTADECANOL; OCTANOIN; PANACATE; PENETRATION ENHANCING AGENT; PENTAZOCINE; PROPYLENE GLYCOL; SUNSOFT; TRIACYLGLYCEROL; TRIOCTANOIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIFFUSION; DRUG ABSORPTION; DRUG EFFECT; DRUG FORMULATION; DRUG TRANSPORT; HAIRLESS MOUSE; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; SKIN ABSORPTION; SKIN PERMEABILITY; TRANSDERMAL PATCH;

ANIMALS; ESTERS; GLYCEROL; MALE; MICE; MICE, INBRED HRS; MYRISTATES; PENTAZOCINE; PERMEABILITY; SKIN ABSORPTION; SOLUBILITY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 34447134862     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.1350     Document Type: Article

References (32)

1. This study was part of Furuishi T., Tomono K., Suzuki T., Fukami T., Worldwide Patent WO2006085521 (2006).
2. Berkowitz B. A., Asling J. H., Shnider S. M., Way E. L., Clin. Pharm. Ther., 10, 320-328 (1969).
3. Brogden R. N., Speight T. M., Avery G. S., Drugs, 5, 6-91 (1973).
4. Mandal S. C., Bhattacharyya M., Ghosal S. K., Drug Dev. Ind. Pharm., 20, 1933-1941 (1994).
5. Mandal S. C., Mandal M., Ghosal S. K., S. T. P. Pharm. Sci., 4, 477-481 (1994).
6. Finnin B. C., Morgan T. M., J. Pharm. Sci., 88, 955-958 (1999).
7. Ho H. O., Huang F. C., Sokoloski T. D., Sheu M. T., J. Pharm. Pharmacol., 46, 636-642 (1994).
8. Kakubari I., Nakamura N., Takayasu T., Yamauchi H., Takayama S., Takayama K., Biol. Pharm. Bull., 29, 146-149 (2006).
9. Morimoto Y., Sugibayashi K., Kobayashi D., Shoji H., Yamazaki J., Kimura M., Int. J. Pharm., 91, 9-14 (1993).
10. Rennol M., Newnan M. S., "Organic Synthesis Collective," Vol. 3, Wiley, New York, 1955, pp. 502-504.
11. Batovska D. I., Tsubota S., Kato Y., Asano Y., Ubukata M., Tetrahedron: Asymmetry, 15, 3551-3559 (2004).
12. Romano D., Falcioni F., Mora D., Molinari F., Buthe A., Ansorge-Schumacher M., Tetrahedron: Asymmetry, 16, 841-845 (2005).
13. Yu C. C., Lee Y.-S., Cheon B. S., Lee S. H., Bull. Korean Chem. Soc., 24, 1229-1231 (2003).
14. Mella M., Fagnoni M., Albini A., Tetrahedron, 57, 555-561 (2001).
15. Hashimoto M., Azuma M., JP Patent 7010754 (1995).
16. Koizumi A., Fujii M., Kondoh M., Watanabe Y., Eur. J. Pharm. Biopharm., 57, 473-478 (2004).
17. Shen W. W., Danti A. G., Bruscato F. N., J. Pharm. Sci., 65, 1780-1783 (1976).
18. Okumura M., Sugibayashi K., Morimoto Y., Chem. Pharm. Bull., 37, 1375-1378 (1989).
19. Jain A. K., Thomas N. S., Panchagnula R., J. Control. Release, 79, 93-101 (2002).
20. Diez-Sales O., Garrigues T. M., Herraez J. V., Belda R., Martin-Villodre A., Herraez M., J. Pharm. Sci., 94, 1039-1047 (2005).
21. Pershing L. K., Lambert L. D., Knutson K., Pharm. Res., 7, 170-175 (1990).
22. Wong C. Y., Guu Y. B., Wang M. T., Wang D. P., Drug Dev. Ind. Pharm., 25, 1209-1213 (1999).
23. Valenta C., Wedenig S., J. Pharm. Pharmacol., 49, 955-959 (1997).
24. Okumura M., Nakamori Y., Sugibayashi K., Morimoto Y., Drug Des. Del., 7, 147-157 (1991).
25. Sato K., Sugibayashi K., Morimoto Y., Int. J. Pharm., 43, 31-40 (1988).
26. Franz J. M., Gaillard A., Maibach H. I., Schweitzer A., Arch. Dermatol. Res., 271, 275-282 (1981).
27. Goto S., Uchida T., Lee C. K., Yasutake T., Zhang J. B., J. Pharm. Sci., 82, 959-963 (1993).
28. Okumura M., Nakamori Y., Yoshida Y., Niwa H., Sugibayashi K., Morimoto Y., Drug Des. Del., 6, 137-148 (1990).
29. Griffin W. C., J. Soc. Cosmet. Chemists, 5, 249-256 (1954).
30. Myoung Y., Choi H. K., Drug Deliv., 9, 121-126 (2002).
31. Park E. S., Chang S. Y., Hahn M., Chi S. C., Int. J. Pharm., 209, 109-119 (2000).
32. Koga T., Watanabe T., Nippon Shokuhin Kogyo Gakkaishi, 15, 297-300 (1968).